Kate Dunlop

Datos Biográficos

ID7801748
NOMBREKate Dunlop
NOMBRESKate
APELLIDODunlop
FIRMADUNLOP K
AFILIACIONESThe Daffodil Centre The University of Sydney, and Cancer Council New South Wales Sydney Australia
ORCID0000-0001-9544-9764
VERIFICADOSí
TOTAL DE OBRAS4
TOTAL DE CITAS0
TOTAL COMO AUTOR4
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2020
AÑO MÁS RECIENTE DE PUBLICACIÓN2026
ÍNDICE H0

  • Reducing Stigma in Lung Cancer Screening

    Open AccessKathleen McFadden, Nathan J Harrison et al.ARTICLEHealth Expectations2026

    INTRODUCTION: Organised lung cancer screening (LCS) programs are being developed worldwide in response to recent landmark trial evidence. Targeting high-risk individuals primarily based on smoking history, LCS faces challenges from smoking-related stigma, which can cause psychological harm and hinder participation. With limited interventions addressing this issue, this study aimed to co-design a communication-based strategy to reduce stigma in th…

  • User Testing of Information Materials Developed for the Australian National Lung Cancer Screening Program

    Open AccessDan Luo, Kate Dunlop et al.ARTICLEHealth Expectations2026

    INTRODUCTION: The Australian National Lung Cancer Screening Program commenced in July 2025. This study aimed to explore the views of community members and the health workforce on the content, language, design and presentation of the draft information materials developed for the general population and health workforce. METHODS: Semi-structured interviews and focus groups were conducted between September and October 2024. Community members potentia…

  • Acceptability of risk‐stratified population screening across cancer types

    Open AccessKate Dunlop, Nicole Rankin et al.ARTICLEHealth Expectations2021

    BACKGROUND: There is mounting evidence of the benefit of risk-stratified (risk-tailored) cancer population screening, when compared to standard approaches. However, shifting towards this approach involves changes to practice that may give rise to implementation challenges. OBJECTIVES: To explore the public's potential acceptance of risk-stratified screening across different cancer types, including reducing screening frequency if at low risk and t…

  • Implementation considerations for offering personal genomic risk information to the public

    Open AccessAmelia K Smit, Gillian Reyes-Marcelino et al.ARTICLEBMC Public Health2020

    Participants felt that offering personal genomic risk information to the general population to inform prevention and early detection recommendations is acceptable, particularly for common, complex conditions such as cancer. Understanding participants' preferences for receiving genomic risk information will assist with communication strategies and health workforce planning. We anticipate that these findings will contribute to the development of im…